Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference22 articles.
1. Prostate-specific antigen testing for prostate cancer: the case for informed consent;McCredie;Med J Aust,1998
2. Prostate specific antigen only progression of prostate cancer;Moul;J Urol,2000
3. Intermittent androgen deprivation therapy for prostate cancer;Rashid;Oncologist,2004
4. Australian Institute of Health and Welfare. Cancer in Australia 1999. Internet. 22-11-2002 [Electronic Citation].
5. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback;Ransohoff;Am J Med,2002
Cited by 102 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis;Advances in Therapy;2024-08-21
2. Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study;European Urology Oncology;2023-12
3. A holistic approach to prostate cancer treatment: natural products as enhancers to a medically minded approach;Medical Oncology;2023-10-31
4. The Association Between Low Preoperative Serum Testosterone and Post-radical Prostatectomy Urinary Function;Urology;2023-10
5. An adaptive information-theoretic experimental design procedure for high-to-low fidelity calibration of prostate cancer models;Mathematical Biosciences and Engineering;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3